Author:
Yamamoto Akira,Kawaguchi Akito,Harada-Shiba Mariko
Reference28 articles.
1. Illingworth R (1993) How effective is drug therapy in heterozygous familial hypercholesterolemia. Am J Cardiol 72: D54–D58.
2. Bilheimer DW (1989) Portacaval shunt and liver transplantation in treatment of familial hypercholesterolemia
3. Grossman M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, Lupien P-J, Wilson JM (1994) Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolemia. Nature Genet 6: 335–341.
4. Yamamoto A, Kojima, S, Harada-Shiba M, Toyota, Y, Takamiya M, Tsushima M, Kishino B, Koga N, Tatami R (1995) Plasmapheresis for prevention and regression of cornary atherosclerosis. Ann NY Acad Sci 748: 429–440.
5. DeGenne JL, Toutaine R, Maunand B, Truffert J, Laudat P (1967) Forme homozygotes cutaneo-tendineuses de Xanthomatose hypercholesterolemique dans une observation familiale exemplaire. Essai de Plasmapherese a titre de traitment heroique. Bull Mem Soc Hop Paris 118: 1377–1402.